Valmont's Q3 Earnings Jump, But YTD Hit by Impairments

TL;DR

**Valmont's Q3 looks good, but don't ignore the massive year-to-date impairment hit – it's a red flag for long-term value.**

AI Summary

Valmont Industries, Inc. reported a significant increase in net earnings attributable to Valmont Industries, Inc. for the thirteen weeks ended September 27, 2025, reaching $99,031 thousand, up from $83,068 thousand in the prior year, representing a 19.2% increase. Diluted EPS also rose to $4.98 from $4.11. However, for the thirty-nine weeks ended September 27, 2025, net earnings attributable to Valmont Industries, Inc. decreased substantially to $182,272 thousand from $270,606 thousand in the same period of 2024, a 32.7% decline, with diluted EPS falling to $7.80 from $13.34. This decline was primarily driven by a $91,337 thousand impairment of long-lived assets and $8,884 thousand in realignment charges during the thirty-nine-week period of 2025, which were not present in 2024. Net sales saw a modest increase for both periods, reaching $1,045,980 thousand for the thirteen weeks and $3,065,842 thousand for the thirty-nine weeks in 2025. Operating income for the thirteen weeks increased to $141,456 thousand from $125,735 thousand, but for the thirty-nine weeks, it dropped to $299,046 thousand from $404,596 thousand. Cash and cash equivalents increased to $226,107 thousand as of September 27, 2025, from $164,315 thousand at December 28, 2024.

Why It Matters

Valmont's mixed financial results present a complex picture for investors. While the strong Q3 net earnings growth of 19.2% is positive, the significant year-to-date decline of 32.7% due to asset impairments and realignment charges raises concerns about underlying business health and future profitability. This could signal a strategic shift or challenges in certain segments, potentially impacting Valmont's competitive standing against peers in infrastructure and agriculture. Employees might face uncertainty if realignment charges indicate ongoing restructuring, and customers could see changes in product or service offerings. The broader market will watch how Valmont navigates these challenges, especially given its role in critical infrastructure sectors.

Risk Assessment

Risk Level: high — The risk level is high due to the significant impairment of long-lived assets totaling $91,337 thousand and $8,884 thousand in realignment charges for the thirty-nine weeks ended September 27, 2025. These non-recurring charges severely impacted year-to-date net earnings, which decreased by 32.7% to $182,272 thousand from $270,606 thousand in the prior year, indicating potential underlying issues or strategic missteps.

Analyst Insight

Investors should scrutinize the nature and future implications of the $91,337 thousand asset impairment and $8,884 thousand realignment charges. Consider holding VMI if you believe these are one-time events leading to a stronger, leaner company, but be prepared for potential continued volatility as the company adjusts.

Financial Highlights

debt To Equity

N/A

revenue

$3,065,842

operating Margin

9.75%

total Assets

N/A

total Debt

N/A

net Income

$182,272

eps

$7.80

gross Margin

30.35%

cash Position

$226,107

revenue Growth

+0.9%

Revenue Breakdown

Key Numbers

• $99.03M — Q3 2025 Net Earnings Attributable to VMI (Increased 19.2% from $83.07M in Q3 2024)
• $182.27M — YTD 2025 Net Earnings Attributable to VMI (Decreased 32.7% from $270.61M in YTD 2024)
• $91.34M — Impairment of Long-Lived Assets (Significant non-recurring charge in YTD 2025)
• $8.88M — Realignment Charges (Non-recurring charge in YTD 2025)
• $4.98 — Q3 2025 Diluted EPS (Increased from $4.11 in Q3 2024)
• $7.80 — YTD 2025 Diluted EPS (Decreased from $13.34 in YTD 2024)
• $1.05B — Q3 2025 Net Sales (Increased from $1.02B in Q3 2024)
• $3.07B — YTD 2025 Net Sales (Increased from $3.04B in YTD 2024)
• $226.11M — Cash and Cash Equivalents (Increased from $164.32M at December 28, 2024)
• 19,699,639 — Shares of Common Stock Outstanding (As of October 24, 2025)

Key Players & Entities

• Valmont Industries, Inc. (company) — registrant
• New York Stock Exchange (regulator) — exchange where VMI is listed
• $99,031 thousand (dollar_amount) — Net earnings attributable to Valmont Industries, Inc. for Q3 2025
• $83,068 thousand (dollar_amount) — Net earnings attributable to Valmont Industries, Inc. for Q3 2024
• $182,272 thousand (dollar_amount) — Net earnings attributable to Valmont Industries, Inc. for YTD 2025
• $270,606 thousand (dollar_amount) — Net earnings attributable to Valmont Industries, Inc. for YTD 2024
• $91,337 thousand (dollar_amount) — Impairment of long-lived assets for YTD 2025
• $8,884 thousand (dollar_amount) — Realignment charges for YTD 2025
• $226,107 thousand (dollar_amount) — Cash and cash equivalents as of September 27, 2025
• Human Resources Committee of the Board of Directors (person) — authorized to grant stock awards

FAQ

Risk Factors

• Supply Chain Disruptions [medium — operational]: The company faces ongoing risks from global supply chain disruptions, which can impact the availability and cost of raw materials and components. For the thirty-nine weeks ended September 27, 2025, product cost of sales increased to $1,945,931 thousand from $1,916,751 thousand in the prior year, indicating potential cost pressures.
• Asset Impairment Charges [high — financial]: Valmont incurred a significant $91,337 thousand impairment of long-lived assets in the thirty-nine weeks ended September 27, 2025. This charge substantially reduced net earnings and indicates potential overvaluation or underperformance of certain assets.
• Realignment Charges [medium — operational]: The company recorded $8,884 thousand in realignment charges during the thirty-nine weeks ended September 27, 2025. These charges suggest restructuring activities or operational adjustments that negatively impacted profitability.
• Interest Rate Fluctuations [low — market]: Interest expense decreased from $46,380 thousand to $30,396 thousand for the thirty-nine-week period, indicating a benefit from lower interest rates or reduced debt. However, future increases in interest rates could negatively impact borrowing costs.
• Foreign Currency Exchange Rate Volatility [medium — regulatory]: The company experienced a foreign currency translation gain of $58,403 thousand in the thirty-nine weeks ended September 27, 2025, compared to a loss of $6,872 thousand in the prior year. Significant fluctuations can impact reported earnings and the value of international operations.

Industry Context

Valmont Industries operates in diverse markets including infrastructure, agriculture, and energy. The company faces competition from global and regional players in each segment. Trends such as increased infrastructure spending, demand for sustainable agricultural practices, and renewable energy development present growth opportunities, but also require adaptation to evolving technologies and regulatory landscapes.

Regulatory Implications

The company must comply with various financial reporting regulations, including U.S. GAAP. The significant impairment charge may attract scrutiny regarding asset valuation practices. Additionally, international operations expose Valmont to diverse regulatory environments and currency controls.

What Investors Should Do

1. Monitor the impact of asset impairments and realignment charges.
2. Analyze segment performance beyond headline sales figures.
3. Evaluate the sustainability of Q3's strong performance.
4. Assess the company's cash generation and management.

Key Dates

• 2025-09-27: End of third quarter reporting period — Key period for financial performance review, showing strong Q3 but significant YTD impact from charges.
• 2024-09-28: End of third quarter reporting period (prior year) — Provides a crucial comparison point for year-over-year performance analysis.
• 2025-12-28: Prior fiscal year-end balance sheet date — Benchmark for current cash and cash equivalents position.

Glossary

Impairment of long-lived assets

A charge taken when the carrying amount of an asset on the balance sheet is deemed unrecoverable or exceeds its fair value. (A significant $91,337 thousand charge in YTD 2025 negatively impacted net earnings, indicating potential issues with asset performance or valuation.)

Realignment charges

Costs associated with restructuring, reorganizing, or making significant changes to a company's operations. (A $8,884 thousand charge in YTD 2025 suggests operational adjustments that reduced profitability.)

Diluted EPS

Earnings per share calculated after accounting for all dilutive potential common shares, such as stock options and convertible securities. (Diluted EPS fell to $7.80 in YTD 2025 from $13.34 in YTD 2024, reflecting the impact of charges on profitability per share.)

Foreign currency translation adjustments

Gains or losses arising from the conversion of financial statements of foreign subsidiaries into the parent company's reporting currency. (A significant gain of $58,403 thousand in YTD 2025 highlights the impact of currency fluctuations on reported results.)

Operating income

Profitability of a company's core business operations before interest and taxes. (Operating income decreased significantly to $299,046 thousand in YTD 2025 from $404,596 thousand in YTD 2024, primarily due to the impairment and realignment charges.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Valmont Industries Inc. presents a mixed financial picture. While net sales showed modest growth for both the thirteen weeks (+$25.8M) and thirty-nine weeks (+$28.1M) ended September 27, 2025, net earnings attributable to Valmont Industries, Inc. saw a strong 19.2% increase in Q3 2025 but a substantial 32.7% decrease year-to-date. This year-to-date decline was heavily influenced by significant non-recurring charges, including a $91.34M impairment of long-lived assets and $8.88M in realignment charges, which were absent in the prior year. Operating income reflects this divergence, increasing in Q3 but falling sharply year-to-date. Cash reserves have strengthened, increasing from $164.32M to $226.11M.

Key Financial Figures

• $1.00 — nge on which registered Common Stock, $1.00 par value VMI New York Stock Exchan

Filing Documents

• vmi-20250927x10q.htm (10-Q) — 2733KB
• vmi-20250927xex31d1.htm (EX-31.1) — 11KB
• vmi-20250927xex31d2.htm (EX-31.2) — 12KB
• vmi-20250927xex32d1.htm (EX-32.1) — 12KB
• 0000102729-25-000053.txt ( ) — 11517KB
• vmi-20250927.xsd (EX-101.SCH) — 45KB
• vmi-20250927_cal.xml (EX-101.CAL) — 71KB
• vmi-20250927_def.xml (EX-101.DEF) — 216KB
• vmi-20250927_lab.xml (EX-101.LAB) — 501KB
• vmi-20250927_pre.xml (EX-101.PRE) — 365KB
• vmi-20250927x10q_htm.xml (XML) — 2786KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Condensed Consolidated Statements of Earnings for the thirteen and thirty-nine weeks ended September 27, 2025 and September 28, 2024 3 Condensed Consolidated Statements of Comprehensive Income for the thirteen and thirty-nine weeks ended September 27, 2025 and September 28, 2024 4 Condensed Consolidated Balance Sheets as of September 27, 2025 and December 28, 2024 5 Condensed Consolidated Statements of Cash Flows for the thirty-nine weeks ended September 27, 2025 and September 28, 2024 6 Condensed Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interests for the thirteen and thirty-nine weeks ended September 27, 2025 and September 28, 2024 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 34 Item 4.

Controls and Procedures

Controls and Procedures 35

— OTHER INFORMATION

PART II — OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 36 Item 1A.

Risk Factors

Risk Factors 36 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36 Item 3. Defaults Upon Senior Securities 36 Item 4. Mine Safety Disclosures 36 Item 5. Other Information 36 Item 6. Exhibits 37

Signatures

Signatures 38 2 Table of Contents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS VALMONT INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (Dollars in thousands, except per-share amounts) (Unaudited) Thirteen weeks ended Thirty-nine weeks ended September 27, September 28, September 27, September 28, 2025 2024 2025 2024 Product sales $ 928,106 $ 922,062 $ 2,745,966 $ 2,725,219 Service sales 117,874 98,113 319,876 312,521 Net sales 1,045,980 1,020,175 3,065,842 3,037,740 Product cost of sales 655,859 659,805 1,945,931 1,916,751 Service cost of sales 71,875 58,677 189,396 192,798 Total cost of sales 727,734 718,482 2,135,327 2,109,549 Gross profit 318,246 301,693 930,515 928,191 Selling, general, and administrative expenses 176,790 175,958 531,248 523,595 Impairment of long-lived assets — — 91,337 — Realignment charges — — 8,884 — Operating income 141,456 125,735 299,046 404,596 Other income (expenses): Interest expense ( 9,738 ) ( 14,313 ) ( 30,396 ) ( 46,380 ) Interest income 1,588 2,080 6,550 5,358 Gain on deferred compensation investments 1,187 1,160 2,730 3,116 Other ( 2,956 ) ( 2,307 ) ( 9,361 ) ( 3,662 ) Total other expenses ( 9,919 ) ( 13,380 ) ( 30,477 ) ( 41,568 ) Earnings before income taxes and equity in loss of nonconsolidated subsidiaries 131,537 112,355 268,569 363,028 Income tax expense (benefit): Current 22,872 46,133 78,507 106,738 Deferred 7,552 ( 16,409 ) 4,996 ( 15,959 ) Total income tax expense 30,424 29,724 83,503 90,779 Earnings before equity in loss of nonconsolidated subsidiaries 101,113 82,631 185,066 272,249 Equity in loss of nonconsolidated subsidiaries ( 21 ) ( 21 ) ( 602 ) ( 60 ) Net earnings 101,092 82,610 184,464 272,189 Loss (earnings) attributable to redeemable noncontrolling interests ( 2,061 ) 458 ( 2,192 ) ( 1,583 ) Net earnings attribu

View Full Filing

View this 10-Q filing on SEC EDGAR